GlassScriptPhysician profile
Jason C Choi
NPI 1407083470
$3,952.22
in general payments reported to CMS, 2019-2025
22 companies · $346 in 2025
The $346 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,122 · 2020: $221 · 2021: $1,189 · 2022: $212 · 2023: $257 · 2024: $606 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700 · Travel and Lodging: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.67 |
| Travel and Lodging | $509.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,043.48 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $801.22 | 2019-2024 | Watchman Flx, Watchman Access System, Bodyguardian |
| Globus Medical, INC. | $509.00 | 2024 | Excelsiusgps Robotic Navigation System |
| Abbott Laboratories | $396.10 | 2019-2025 | Perclose Prostyle, Aveir |
| Amgen INC. | $239.13 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $221.10 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.73 | 2019-2022 | |
| Medtronic Vascular, INC. | $118.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $83.68 | 2019-2023 | |
| Edwards Lifesciences Corporation | $59.98 | 2024-2025 | |
| Amarin Pharma, INC. | $51.51 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $44.16 | 2019 | |
| Abiomed | $40.48 | 2025 | |
| Inari Medical, INC. | $40.00 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biosense Webster, INC. | $33.38 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventice Services, LLC | $31.17 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $26.51 | 2019 | |
| Becton, Dickinson and Company | $20.31 | 2025 | True Flow |
| Astrazeneca Pharmaceuticals LP | $17.30 | 2019 | |
| Cardiva Medical, INC. | $16.69 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $16.09 | 2019 | |
| Getinge USA Sales, LLC | $12.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.